RS
Reeta Sehgal
About Reeta Sehgal
Data last updated:
Reeta Sehgal is a Director at Pharmashots Media Private Limited (since 2023). The companies operate in Media and Publishing and Information Technology. Pharmashots Media Private Limited reported revenue of ₹17.6 Lakh (FY 2025). Earlier, Reeta Sehgal was a Director at Octavus Consulting Private Limited (2017–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pharmashots Media Private Limited U63122UP2023PTC178000 | Director | 10 Mar 2023 | 2023 | ₹17.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Octavus Consulting Private Limited U93000DL2017PTC321503 | Director | 31 Jul 2017 | 2017 | ₹2.18 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Reeta Sehgal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sobaran Singh | 07895843 | Pharmashots Media Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Reeta Sehgal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reeta Sehgal
Reeta Sehgal currently holds 1 directorship: Pharmashots Media Private Limited (Director, since 10 Mar 2023, revenue ₹17.6 Lakh (FY 2025)).
Reeta Sehgal was first appointed on 31 Jul 2017 as Director at Octavus Consulting Private Limited. The most recent appointment on record is 10 Mar 2023 at Pharmashots Media Private Limited.
Reeta Sehgal held 1 earlier board appointment: Octavus Consulting Private Limited (Director, 31 Jul 2017 to 05 Aug 2025).
The current boards of Reeta Sehgal's companies include Sobaran Singh (Pharmashots Media Private Limited).